Building trust and agency: we recommend inviting all athletes to participate in interviews regardless of SMHAT-1 scores, as this enables rapport-building, forming a professional alliance, and ...
An expert provides answers to readers’ questions regarding different aspects of the kidney cancer experience, such as protein intake and clinical trials. From treatment decisions to protein intake, ...
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors Proactive dietary ...
In this video interview, Krishna Cheriath, vice president and head of clinical research digital data and AI at Thermo Fisher Scientific, argues that effective patient-centered AI must go beyond direct ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results